As of now, Michael Costa has not exercised or received any vested stock options for 2023, meaning his wealth is still primarily tied to his salary and bonuses. This shows his commitment to the company’s future growth rather than immediate...

As of now, Michael Costa has not exercised or received any vested stock options for 2023, meaning his wealth is still primarily tied to his salary and bonuses. This shows his commitment to the company’s future growth rather than immediate personal gain. The company, Sabra Healthcare, continues to be closely monitored, reflecting his strategic approach to managing finance. From previous holdings and performance metrics, it’s clear he’s invested in seeing long-term success for both himself and Sabra. This year’s compensation package of over $2.4 million underscores this dedication, but it's interesting to note that he is yet to tap into stock options, suggesting he’s banking on future performance. His financial journey at Sabra will be crucial in shaping how he moves wealth, emphasizing stability and growth rather than quick returns.